Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (291-300 of 348) with videos related to

Pageof 35
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2019
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)Martin J Edelman, Mary W Redman, Kathy S Albain, et al.
Allergy|May 29, 2015
Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrateB L Zuraw, M Cicardi, H J Longhurst, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 1, 2004
Development of required postgraduate palliative care training for internal medicine residents and medical oncology fellowsDouglas D Ross, Deborah Shpritz, Carla S Alexander, et al.
Clinical and Translational Science|January 22, 2016
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics ModelingC H Li, R R Bies, Y Wang, et al.
Cancer|October 22, 2018
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patientsThomas E Stinchcombe, Wen Fan, Steven E Schild, et al.
Cancer Letters|September 5, 2025
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in BloodDaniel L Adams, Massimo Cristofanilli, Steven H Lin, et al.
Clinical Lung Cancer|November 12, 2019
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative IntentStephanie R Rice, Melissa A L Vyfhuis, Katherine A Scilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.
JCO Oncology Practice|September 30, 2020
Benchmarks for Academic Oncology FacultyLowell Anthony, George Atweh, Ravi Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
Pageof 35

Showing results (291-300 of 348) with videos related to

Sort By:
Pageof 35
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2019
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)Martin J Edelman, Mary W Redman, Kathy S Albain, et al.
Allergy|May 29, 2015
Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrateB L Zuraw, M Cicardi, H J Longhurst, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 1, 2004
Development of required postgraduate palliative care training for internal medicine residents and medical oncology fellowsDouglas D Ross, Deborah Shpritz, Carla S Alexander, et al.
Clinical and Translational Science|January 22, 2016
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics ModelingC H Li, R R Bies, Y Wang, et al.
Cancer|October 22, 2018
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patientsThomas E Stinchcombe, Wen Fan, Steven E Schild, et al.
Cancer Letters|September 5, 2025
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in BloodDaniel L Adams, Massimo Cristofanilli, Steven H Lin, et al.
Clinical Lung Cancer|November 12, 2019
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative IntentStephanie R Rice, Melissa A L Vyfhuis, Katherine A Scilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.
JCO Oncology Practice|September 30, 2020
Benchmarks for Academic Oncology FacultyLowell Anthony, George Atweh, Ravi Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
Pageof 35